Skip to main content
. 2024 Dec 6;15:1503704. doi: 10.3389/fendo.2024.1503704

Table 1.

Studies on population characteristics and blood concentrations of individual FFA species in cardiovascular subjects and controls of patients with T2DM.

Country Year Number of subjects (Control vs Case) Match or not+ Affected blood vessels Case group definition Research Conclusion Sample type
The total level of FFA (15) India 1995 164:213 Unmatched Coronary - Higher FFA levels seem to be a predictor of CHD in diabetes patients, exceeding the effect of abnormal lipoproteins. Plasma
(55) Sweden 2000 140:343 Unmatched Coronary,
cerebrovascular
- High NEFA concentrations in healthy offspring with a family history of diabetes were significantly associated with their parents’ myocardial infarction and stroke. Serum
(16) Japan 2002 23:51 Age-matched Coronary Medial thickness of intima without plaque segment [IMT] Serum NEFA levels independently predict the extent of plaque segmental stenosis in diabetes patients, but not in diabetes subjects. Serum
(56) Canada 2002 99:103 Age, body mass index, smoking habits and alcohol intake-matched Coronary Diagnostic electrocardiogram (ECG) changes or meets the following two criteria:
Typical chest pain lasts for at least 20 minutes,
Abnormal creatine kinase levels should be at least twice the upper limit of normal
Typical chest pain lasts for at least 20 minutes, with abnormal creatine kinase levels at least twice the upper limit of normal.
Elevated plasma FFA concentration is associated with increased risk of ischemic heart disease. Plasma
(17) Spain 2010 20:20 Unmatched Carotid artery - The presence of NEFA in the new intima of diabetes plaque increased. The level of NEFA in atherosclerotic plaque of diabetes was higher than that of non-diabetes subjects. NEFA may occur locally and lead to local inflammation. serum and plaque
(57) China 2011 51:34 Unmatched Coronary coronary angiography The levels of FFA and hs CRP in serum are closely related to type 2 diabetes and diabetes with coronary atherosclerotic heart disease. Serum
(58) China 2014 103:59 Unmatched Coronary CTnT ≥ 0.01 ng/L+other evidence There is a positive correlation between serum FFA levels and HDL levels in T2DM and the control group. Serum
(59) China 2016 45:50 Unmatched Coronary Coronary CT scan T2DM combined with CHD coronary plaques are mainly soft plaques and mixed plaques, with extensive coronary artery lesions. Carotid ultrasound shows that the more peripheral vascular plaques and the more branches of coronary artery lesions, the more severe the lesions. Combining CCTA, carotid ultrasound, hsC-RP, and FFA levels in clinical practice can improve the diagnosis rate of T2DM complicated with CHD. Serum
(60) China 2017 79:84 Unmatched Coronary coronary angiography FFA, Hcy, CRP, FPG are positively correlated with coronary heart disease in elderly patients with type 2 diabetes. Serum
(18) America 2018 40 - - The increase in plasma FFA within the physiological range observed in obesity and T2DM induces endothelial activation, vascular inflammation, and thrombosis markers in healthy subjects. Plasma
(20) China 2019 1039:1606 Unmatched Coronary coronary angiography Baseline FFA levels are associated with prognosis in patients with DM and pre DM CAD. Serum
(19) China 2020 70:232 Unmatched Coronary,
carotid artery
coronary angiography, Carotid ultrasound Elevated FFA levels seem to be associated with the presence and severity of CAD and CAP in T2DM patients. Plasma
(61) China 2021 84:80 Unmatched Coronary coronary angiography The serum FFA level is independently correlated with severe coronary artery calcification and may have a certain predictive ability for severe coronary artery calcification. The DM group has the strongest correlation. Serum
FFA profile (62) China 2011 55:55 Age and sex-matched Carotid artery, femoral artery, internal iliac artery Carotid artery intima-media thickness, femoral artery intima-media thickness, iliac artery intima-media thickness
Using high-resolution color ultrasound measurement,
Patients with IMT>1.0mm in any part and/or plaques in the field of view without clinical manifestations
Defined as subclinical atherosclerosis (subclinical atherosclerosis)
Saturated fatty acids (C16:0, C18:0), monounsaturated fatty acids (C18:1)
Total fatty acid (TFA) is associated with subclinical atherosclerosis in type 2 diabetes and is the most common
Significant influencing factors.
Plasma
(63) China 2016 36:137 Unmatched Coronary,
cerebrovascular,
peripheral vascular
Clinical diagnosis includes coronary heart disease, cerebrovascular disease, peripheral vascular disease, and hypertension Comparison of fatty acid composition between large vessel disease groups: TFA, MUFA, SFA, and C16:0, C18:0, C18:1 significantly increased with the severity of vascular disease. Serum
(64) Japan 2017 533:144 Unmatched Coronary Pathological Q waves are observed on the electrocardiogram, and there are areas of viable myocardial loss detected on imaging PMI patients with DM have lower levels of EPA/AA and DHA/AA. The use of statins may affect DHA/AA, but not EPA/AA, so the EPA/AA ratio is a better biomarker for evaluating cardiovascular events. Serum
(65) China 2021 35:68 Unmatched Carotid artery Carotid artery ultrasound shows that the intima-media thickness (IMT) f 1.2mm/IMT ≥ 1.5mm and/or the formation of atherosclerotic plaques are consistent 1. The composition of blood free fatty acid profiles in patients with T2DM combined with AS and those with T2DM alone
In terms of differences, the levels of C16:0 and C18:0 were significantly higher in patients with T2DM alone.
2. C16:0 is the main influencing factor of atherosclerosis in type 2 diabetes patients,
Significantly increase the risk of atherosclerosis.
Serum
(66) China 2022 134:126 Unmatched Coronary Acute myocardial infarction (MI), asymptomatic myocardial infarction, or previous coronary artery surgery Multivariate logistic regression analysis showed that after adjusting for confounding factors and other risk factors, dozens of FFAs were independent risk factors for CHD. Plasma

+ Match refers to the consistency of certain characteristics between the case group and the control group.